Fas Ligand (CD95L) and Cancer Gene Therapy

被引：0
|
作者：
Gary J. Nabel
机构：
[1] National Institutes of Health,
[2] Vaccine Research Center,undefined
来源：
Nature Biotechnology | 1999年 / 17卷 / Suppl 4期
关键词：
D O I：
10.1038/70149
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 25
相关论文
共 50 条
  • [31] Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity
    Medana, I
    Li, ZX
    Flügel, A
    Tschopp, J
    Wekerle, H
    Neumann, H
    JOURNAL OF IMMUNOLOGY, 2001, 167 (02): : 674 - 681
  • [32] Enhanced expression of Fas ligand (CD95L) on T cells after segmental allergen provocation in asthma
    Krug, N
    Tschernig, T
    Balke, K
    Erpenbeck, VJ
    Meyer, L
    Bode, U
    Hohlfeld, JM
    Pabst, R
    Fabel, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (04) : 649 - 655
  • [33] Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival
    Neuber, Karsten
    Eidam, Bettina
    ONKOLOGIE, 2006, 29 (8-9): : 361 - 365
  • [34] Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration
    Bechmann, I
    Lossau, S
    Steiner, B
    Mor, G
    Gimsa, U
    Nitsch, R
    GLIA, 2000, 32 (01) : 25 - 41
  • [35] CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract:: fictions and facts
    Sträter, J
    Möller, P
    VIRCHOWS ARCHIV, 2003, 442 (03) : 218 - 225
  • [36] Upregulation of Fas-FasL (CD95/CD95L)-mediated epithelial apoptosis in pouchitis
    Bennett, MW
    Coffey, JC
    Wang, JH
    Neary, P
    O'Connell, J
    Shanahan, F
    Redmond, HP
    Kirwan, WO
    GASTROENTEROLOGY, 2001, 120 (05) : A185 - A185
  • [37] A Novel Tetravalent CD95/Fas Fusion Protein With Superior CD95L/FasL Antagonism
    Lang, Isabell
    Paulus, Oliver
    Zaitseva, Olena
    Wajant, Harald
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2025, 93 (02) : 441 - 451
  • [38] CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts
    J. Sträter
    P. Möller
    Virchows Archiv, 2003, 442 : 218 - 225
  • [39] CD95L mRNA is toxic to cancer cells
    Putzbach, William
    Haluck-Kangas, Ashley
    Gao, Quan
    Sarshad, Aishe A.
    Bartom, Elizabeth
    Stults, Austin
    Qadir, Abdul S.
    Scholtens, Denise M.
    Hafner, Markus
    Peter, Marcus
    CANCER RESEARCH, 2018, 78 (13)
  • [40] CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathways
    Haymour, Layla
    Jean, Mickael
    Smulski, Cristian
    Legembre, Patrick
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (06):
12345